Payer value proposition development and construction involves the testing of potential value messages (VMs) associated with the clinical and economic evidence for a therapeutic and their further development with the client and associated advisors. It is also important to have a deep understanding of the potential reimbursement challenges and potential questions that may arise from payers and budget holders.
Value Messages form the skeleton of the GVD/AMCP dossier and link the evidentiary base to therapeutic value. We use the CID framework: Credibility, Important, and Differentiation of the value message to test potential messages with key stake holders. We can also undertake workshops to gain final consensus on VMs that will form the skeleton of the GVD